Frontiers | The Problem of Childhood Hypoglycemia

About this Research Topic

This Research Topic is currently accepting articles, but is closing soon.

1. Check author guidelines

Background

This collection is the third volume of the Research Topic The Problem of Childhood Hypoglycemia

Hypoglycemia in infants and children is common and is caused by a number of sources. Childhood hypoglycemia has the potential to cause brain damage leading to lifelong neurodisability. However, definitions and clinical management of hypoglycemia remain variable, given uncertainty over thresholds of harm and absence of robust clinical evidence for appropriate treatment. It is important to synthesize our current understanding of the etiology of mild and severe forms of hypoglycemia to formulate treatment strategies that are effective and cause minimal harm.

The investigation and treatment of hypoglycemia in young infants and children remains variable due to an absence of evidence and uniform consensus among pediatricians and neonatologists. This Research Topic aims to align basic science understanding of the biology of glucose regulation, provide rational understanding of thresholds of hypoglycemia, and develop rational therapy strategies in severe disorders of hypoglycemia such as congenital hyperinsulinism.

We welcome researchers to submit original research, reviews, and mini reviews that:

• Collate current evidence supporting the understanding of pathways of hypoglycemia

• Discuss etiologies of hypoglycemia disorders and assess evidence for different strategies of treatment for optimal outcomes

• Review thresholds of neonatal hypoglycemia to prevent hypoglycemia related brain injury while reducing harm from over-treatment

• Review the patient voice in hypoglycemia and pursue perspectives of patient charities and organizations aiming to push boundaries of care through improved diagnostics and treatment

• Review limits and possibilities of current and future investigations in hypoglycemia

• Describe new treatments to improve patient outcomes

*Prof. Banerjee works at the Royal Manchester Children’s Hospital, the clinical trial site for Zealand Pharma, and is the Primary Investigator for a Growth Hormone study supported by Merck.

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

Case Report
Clinical Trial
Editorial
FAIR² Data
General Commentary
Hypothesis and Theory
Methods
Mini Review
Opinion

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: hypoglycemia, pediatrics, congenital hyperinsulinism, glucose regulation

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.